Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01528930
What this trial is testing

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

Who this might be right for
Pulmonary Non-tuberculous Mycobacterial Lung Disease
Samsung Medical Center
Large-scale testing (Phase 3)UnknownNCT05575518
What this trial is testing

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Who this might be right for
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama 414
Not applicableUnknownNCT04721080
What this trial is testing

Pulmonary Tuberculosis Sequelae in Patients With COPD

Who this might be right for
CopdTuberculosisQuality of Life
Izmir Katip Celebi University 150
Not applicableStudy completedNCT04048018
What this trial is testing

Performance Evaluation of the VIDAS TB-IGRA Assay.

Who this might be right for
Active TuberculosisLatent Tuberculosis InfectionNon-Tuberculous Mycobacterial (NTM) Pneumonia
BioMérieux 2,401
Not applicableLooking for participantsNCT07077213
What this trial is testing

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

Who this might be right for
Tuberculosis, Pulmonary
Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)Study completedNCT03199339
What this trial is testing

Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Global Alliance for TB Drug Development 74
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableStudy completedNCT03822156
What this trial is testing

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Who this might be right for
TuberculosisTuberculosis, PulmonaryCavity+5 more
University of Ulsan 500
Not applicableLooking for participantsNCT07234929
What this trial is testing

Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent

Who this might be right for
Lung CancerTuberculosis (TB)Chat-based Mobile Application+2 more
Gia Dinh People Hospital 2,692
Post-approval studies (Phase 4)Study completedNCT00495339
What this trial is testing

MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Sanofi 100
Large-scale testing (Phase 3)Study completedNCT04721795
What this trial is testing

Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis
Obafemi Awolowo University Teaching Hospital 150
Not applicableStudy completedNCT02331056
What this trial is testing

Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?

Who this might be right for
Pulmonary NeoplasmPulmonary Tuberculosis
Samsung Medical Center 79